Munich, Germany: A proportion of idiopathic pulmonary fibrosis (IPF) cases may be linked with asbestos exposure, according to the results of a new study. If confirmed, the findings would mean that current treatment strategies need to be altered as people with a history of asbestos exposure are not currently able to access new treatments for IPF.
The research, which was presented at the European Respiratory Society's International Congress today (09 September 2014), provided new mortality data for IPF, asbestosis and mesothelioma.